Fortis Healthcare reports details of listed debt securities as of September 30, 2025
Fortis Healthcare reported details of its listed debt securities issued via private placement as of September 30, 2025, as per SEBI regulations, totaling ₹1550 crore outstanding.
This is a standard regulatory disclosure of existing debt instruments and does not announce a new fundraising event, a change in debt terms, or any other material event that would significantly affect the company's operations or financial position. Therefore, its market impact is expected to be low.
The announcement is a routine compliance filing providing factual details about the company's existing listed debt securities. It does not contain any new financial performance data, strategic developments, or forward-looking statements that would indicate a positive or negative outlook.
Fortis Healthcare Limited has submitted a statement detailing its listed debt securities issued through private placement, as mandated by the SEBI Master Circular dated May 22, 2024. The report provides information as of September 30, 2025, for three distinct debt securities: * ISIN INE061F07044: Issued on December 19, 2024, maturing on December 19, 2029, with a coupon rate of 8.486% p.a. for Year 1 (reset annually thereafter). The payment frequency is annual. An amount of ₹500 crore was issued, and ₹500 crore remains outstanding. * ISIN INE061F07051: Issued on December 19, 2024, maturing on December 19, 2029, with a coupon rate of 8.486% p.a. for Year 1 (reset annually thereafter). The payment frequency is annual. An amount of ₹500 crore was issued, and ₹500 crore remains outstanding. * ISIN INE061F07069: Issued on December 19, 2024, maturing on December 19, 2029, with a coupon rate of 8.486% p.a. for Year 1 (reset annually thereafter). The payment frequency is annual. An amount of ₹550 crore was issued, and ₹550 crore remains outstanding.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.